capsule experience - MG Lorenzatto

More documents

Recommendations

Info

Chapter 10 M2A ® Figure 10.1a 20 days post-transplant. Blunted and ridge-shaped whitish villi and hyperemic spot in a patient examined 20 days after transplantation. Figure 10.1c Histology 20 days post-transplant. Normal ileal mucosa (H&E). M2A ® Figure 10.1b 20 days post-transplant. Same patient as Figure 10.1a. M2A ® Transplantation Figure 10.2a 46 days post-transplant. Blunted villi in a patient examined at 6 weeks after transplantation. 113
114 Chapter 10 M2A ® Figure 10.2b 46 days post-transplant. Same patient as figure 10.2a. M2A ® Figure 10.2d 46 days post-transplant. Villous architecture more preserved here, same patient as before. M2A ® Figure 10.2c 46 days post-transplant. Same patient as previous figure. M2A ® Figure 10.2e 2 months post-transplant. Normal distal ileum. Transplantation
Page 1 and 2:
Atlas of Capsule Endoscopy Editors:
Page 3 and 4:
Atlas of Capsule Endoscopy Marisa H
Page 5 and 6:
Acknowledgments We would like to th
Page 7 and 8:
Table of contents Development of th
Page 9 and 10:
4 Development of the Swallowable Vi
Page 11 and 12:
Notes From the Inventor Gavriel J.
Page 13 and 14:
10 Chapter 1 THE OPTICAL DOME The o
Page 15 and 16:
12 Chapter 1 c. Conscious sedation
Page 17 and 18:
16 Chapter 2 Typical timing of a ca
Page 19 and 20:
18 Chapter 2 Figure 1. Intializing
Page 21 and 22:
20 Chapter 2 Figure 5. Time Capsule
Page 23 and 24:
24 Chapter 3 becomes very obvious.
Page 25 and 26:
26 Chapter 3 M2A ® M2A ® Figure 3
Page 27 and 28:
28 Chapter 3 M2A ® Figure 3.5b Nor
Page 29 and 30:
30 Chapter 3 M2A ® M2A ® Figure 3
Page 31 and 32:
Chapter 4 Inflammatory Diseases of
Page 33 and 34:
Chapter 4 6 Sayek I, Aran O, Uzunal
Page 35 and 36:
Chapter 4 M2A ® M2A ® Figure 4.4a
Page 37 and 38:
Chapter 4 M2A ® Figure 4.5f Pseudo
Page 39 and 40:
Chapter 4 M2A ® Figure 4.6f Extens
Page 41 and 42:
Chapter 4 M2A ® M2A ® Figure 4.10
Page 43 and 44:
Chapter 4 M2A ® Figure 4.15a Jejun
Page 45 and 46:
48 Chapter 5 with small bowel tumor
Page 47 and 48:
50 Chapter 5 M2A ® Figure 5.4a Lar
Page 49 and 50:
52 Chapter 5 M2A ® Figure 5.7b Sam
Page 51 and 52: 54 Chapter 5 M2A ® Figure 5.11a A
Page 53 and 54: 56 Chapter 5 Figure 5.12c Biopsy of
Page 55 and 56: 58 Chapter 5 M2A ® Figure 5.15a Ad
Page 57 and 58: 60 Chapter 5 M2A ® Figure 5.18a No
Page 59 and 60: Chapter 6 Iatrogenic Diseases David
Page 61 and 62: Chapter 6 Iatrogenic Diseases M2A
Page 67 and 68: Chapter 7 Vascular Abnormalities Ma
Page 69 and 70: Chapter 7 References and Suggested
Page 71 and 72: Chapter 7 M2A ® Figure 7.2 74 year
Page 73 and 74: Chapter 7 M2A ® Figure 7.8a Small
Page 75 and 76: Chapter 8 Malabsorption Gerard Gay,
Page 77 and 78: Chapter 8 References and Suggested
Page 79 and 80: Chapter 8 Endoscopic management of
Page 81 and 82: Chapter 8 M2A ® M2A ® Figure 8.1e
Page 83 and 84: Chapter 8 Figure 8.3a Enteroscopy p
Page 85 and 86: Chapter 8 M2A ® M2A ® Figure 8.3i
Page 87 and 88: Chapter 8 M2A ® Figure 8.4a Celiac
Page 89 and 90: Chapter 8 Figure 8.6e Histological
Page 91 and 92: Chapter 8 Figure 8.7f Higher magnif
Page 93 and 94: Chapter 8 M2A ® Figure 8.9a 38 yea
Page 95 and 96: 104 Chapter 9 Our preliminary data
Page 97 and 98: 106 Chapter 9 M2A ® M2A ® Figure
Page 99 and 100: 108 Chapter 9 M2A ® Figure 9.4a 11
Page 101: 112 Chapter 10 transplant. Indicati
Page 105 and 106: 116 Chapter 10 M2A ® Figure 10.4c
Page 107 and 108: 120 Chapter 11 CONCLUSION During th
Page 109 and 110: 122 Chapter 11 M2A ® Figure 11.4a
Page 111 and 112: Contributors Carla Abbiati, M.D. Un
Page 113 and 114: 128 Contributors (continued) Sandor
Page 115 and 116: 130 Contributors (continued) Ana Sa
show all

capsule experience - MG Lorenzatto

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?